The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

HHS has ended a government-funded program that distributed free COVID-19 tests to community organizations, a department ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

Merck held talks over a potential $3 billion acquisition of MoonLake Immunotherapeutics, as it seeks to replenish its drug pipeline ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Some of the layoffs will be to compensate for those rehired after the first wave. Meanwhile, Politico reports on how HHS had no intention of rehiring 20% of the departments' fired employees, as ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...

Despite Health Secretary Robert F Kennedy Jr’s announcement ending covid-19 vaccine recommendations for healthy children and pregnant women, the Centers for Disease Control and Prevention (CDC) has ...

The HHS terminated funding for for Moderna's avian influenza vaccine due to safety concerns with mRNA vaccines.

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...